Sort   by:  
 Page size 
UnknownEarly initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants-The STOP-AD randomised controlled trial.
Not available
S-EPMC10952678 | biostudies-literature
UnknownProminent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
Not available
S-EPMC10996108 | biostudies-literature
UnknownDisclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial.
Not available
S-EPMC11847990 | biostudies-literature
UnknownChronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD.
Not available
S-EPMC4096128 | biostudies-literature
UnknownUpregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice.
Not available
S-EPMC7294908 | biostudies-literature
UnknownAge-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice.
Not available
S-EPMC4122177 | biostudies-literature
UnknownComparing Functional Consequences of Human iPSC-Microglia and Neural Stem Cell-Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease.
Not available
S-EPMC12723720 | biostudies-literature
UnknownCommunity recruitment of underrepresented populations to the AHEAD 3-45 preclinical AD trial using novel partnerships with nursing and community-based organizations: Lessons and outcomes.
Not available
S-EPMC11485091 | biostudies-literature
UnknownCathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40.
Not available
S-EPMC7339583 | biostudies-literature
UnknownGlutamate's Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer's Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion Channel.
Not available
S-EPMC10779680 | biostudies-literature
Sort   by:  
 Page size